本文選題：動(dòng)脈粥樣硬化 + CD40��； 參考：《遼寧中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：目的:觀察電針內(nèi)關(guān)、關(guān)元、足三里穴對(duì)動(dòng)脈粥樣硬化模型家兔的干預(yù)作用,通過(guò)檢測(cè)各組血清中CD40、CD40L的表達(dá)水平,探討電針內(nèi)關(guān)、關(guān)元、足三里穴抑制動(dòng)脈粥樣硬化模型家兔炎癥反應(yīng)的作用機(jī)制。材料與方法:應(yīng)用26只健康雄性新西蘭雄性家兔(每只2-2.5kg,2-3月齡),適應(yīng)性喂養(yǎng)一周后,隨機(jī)分為正常組和造模組,其中正常組7只,造模組19只。正常組給予普通飼料喂養(yǎng),造模組給予高脂飼料和普通飼料混合喂養(yǎng),高脂喂養(yǎng)4周后對(duì)造模組行頸動(dòng)脈球囊損傷術(shù)。高脂喂養(yǎng)8周后,從正常組和造模組中各隨機(jī)選取1只家兔檢測(cè)造模是否成功,采用HE染色的檢測(cè)方法觀察家兔頸動(dòng)脈粥樣硬化斑塊病理形態(tài)學(xué)變化。將造模組(18只)隨機(jī)分為三組(每組n=6):模型組、電針組、西藥組。電針組選取內(nèi)關(guān)(雙側(cè))、足三里(雙側(cè))、關(guān)元穴進(jìn)行治療,每日1次;西藥組給予阿托伐他汀鈣片懸濁液1mg/kg/d灌胃給藥。6天為1療程,療程間休息1日,共4個(gè)療程。第四個(gè)療程治療結(jié)束后對(duì)所有家兔進(jìn)行處死,耳緣經(jīng)脈采血,分離血清,取頸動(dòng)脈固定于4%多聚甲醛中48小時(shí)后HE染色,分析頸動(dòng)脈的病理學(xué)改變,采用酶聯(lián)免疫吸附測(cè)定法對(duì)血清中CD40、CD40L進(jìn)行分析檢測(cè)。結(jié)果:1.電針內(nèi)關(guān)、關(guān)元、足三里穴對(duì)血清中CD40的影響:與正常組進(jìn)行比較,模型組、電針組、西藥組血清中CD40的表達(dá)增高,差異具有統(tǒng)計(jì)學(xué)意義(P0.05);與模型組比較,電針組和西藥組家兔血清中CD40表達(dá)水平降低,差異有統(tǒng)計(jì)學(xué)意義(P0.05);與西藥組比較,電針組血漿CD40水平無(wú)明顯差異,差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)。2.電針內(nèi)關(guān)、關(guān)元、足三里穴對(duì)血清中CD40L的影響:與正常組進(jìn)行比較,模型組、電針組、西藥組血清中CD40L的表達(dá)增高,差異具有統(tǒng)計(jì)學(xué)意義(P0.05);與模型組比較,電針組和西藥組家兔血清中CD40L水平降低,差異有統(tǒng)計(jì)學(xué)意義(P0.05);與西藥組比較,電針組血CD40L水平無(wú)明顯差異,差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:1.降低血清中CD40的濃度,對(duì)動(dòng)脈粥樣硬化模型家兔血清中炎癥反應(yīng)起到抑制作用,體現(xiàn)了應(yīng)用電針刺激內(nèi)關(guān)、關(guān)元、足三里穴位的通絡(luò)、活血、化痰功效對(duì)動(dòng)脈粥樣硬化的預(yù)防及治療可能具有積極的意義。2.降低血清中CD40L濃度,對(duì)動(dòng)脈粥樣硬化模型家兔血清中炎癥反應(yīng)起到抑制作用,體現(xiàn)了應(yīng)用電針刺激內(nèi)關(guān)、關(guān)元、足三里穴位的通絡(luò)、活血、化痰功效對(duì)動(dòng)脈粥樣硬化的預(yù)防及治療可能具有積極的意義。
[Abstract]:Objective: to observe the intervention effect of electroacupuncture at Neiguan, Guanyuan and Zusanli on atherosclerosis model rabbits, and to investigate the expression of CD40T CD40L in serum of each group, and to explore the effect of electroacupuncture on Neiguan and Guanyuan. The mechanism of Zusanli (Zusanli) on inhibiting inflammatory response in atherosclerotic rabbits. Materials and methods: Twenty-six healthy male New Zealand rabbits (2-2.5kg / 2 ~ (-3) months old) were randomly divided into normal group (n = 7) and model group (n = 19) after a week of adaptive feeding. The normal group was fed with normal diet, the model group was fed with high fat diet and common feed, and the model group was treated with carotid artery balloon injury after 4 weeks of high fat feeding. After 8 weeks of high fat feeding, one rabbit was randomly selected from the normal group and the model group to detect whether the model was successful or not, and the pathological morphology of carotid atherosclerotic plaque was observed by HE staining. The model group (n = 18) was randomly divided into three groups: model group, electroacupuncture group and western medicine group. In the electroacupuncture group, Neiguan (bilateral and Zusanli) was treated once a day, and the western medicine group was treated with 1mg/kg/d, which was administered by oral administration of Atto calcareous tablets for 6 days, with 1 course of rest between the two courses of treatment for 4 courses. At the end of the fourth course of treatment, all rabbits were killed. Blood was collected from the meridians of the ear margin, serum was isolated, and the carotid artery was fixed in 4% paraformaldehyde for 48 hours. The pathological changes of the carotid artery were analyzed. Enzyme linked immunosorbent assay (Elisa) was used to detect CD40 C 40 L in serum. The result is 1: 1. The effect of electroacupuncture at Neiguan, Guanyuan and Zusanli on CD40 in serum: compared with normal group, the expression of CD40 in serum of model group, electroacupuncture group and western medicine group was higher than that of model group, and the difference was statistically significant (P 0.05). Compared with the western medicine group, there was no significant difference in the plasma CD40 level between the electroacupuncture group and the western medicine group, but there was no significant difference between the electroacupuncture group and the western medicine group. The effect of electroacupuncture at Neiguan, Guanyuan and Zusanli on CD40L in serum: compared with normal group, the expression of CD40L in serum of model group, electroacupuncture group and western medicine group was higher than that of model group, and the difference was statistically significant (P 0.05). The serum CD40L level in the electroacupuncture group and the western medicine group was lower than that in the western medicine group (P 0.05), but there was no significant difference in the serum CD40L level between the electroacupuncture group and the western medicine group (P 0.05). Conclusion 1. Lowering the concentration of CD40 in serum can inhibit the inflammatory reaction in the serum of atherosclerotic model rabbits. It reflects the application of electroacupuncture to stimulate Neiguan, Guanyuan, Zusanli acupoints to clear the collaterals and promote blood circulation. Resolving phlegm effect may have positive significance to the prevention and treatment of atherosclerosis. Lowering the concentration of CD40L in serum can inhibit the inflammatory reaction in the serum of atherosclerosis model rabbits. It reflects the stimulation of acupoints of Neiguan, Guanyuan and Zusanli by electroacupuncture, which can activate the blood circulation and the collaterals of the acupoints of Guanyuan, Guanyuan and Zusanli. The effect of resolving phlegm may be of positive significance to the prevention and treatment of atherosclerosis.
【學(xué)位授予單位】：遼寧中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R245;R-332

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 袁偉;;益氣滋陰活血湯聯(lián)合西藥治療冠心病的療效及對(duì)CD40/CD40L表達(dá)的影響[J];現(xiàn)代醫(yī)學(xué);2016年12期

2 陳小麗;岳增輝;劉麗;王艷;李萍;文琪琦;魏歆然;;足三里穴的古今應(yīng)用與研究[J];針灸臨床雜志;2016年07期

3 何武;;清熱解毒法治療頸動(dòng)脈粥樣硬化的研究進(jìn)展[J];中西醫(yī)結(jié)合心腦血管病雜志;2016年12期

4 韋寧高;;活血化瘀中藥對(duì)急性冠狀動(dòng)脈綜合征的治療效果[J];中醫(yī)臨床研究;2016年17期

5 孫少衛(wèi);童文娟;謝雪嬌;廖端芳;;動(dòng)脈粥樣硬化的中西醫(yī)觀[J];中國(guó)動(dòng)脈硬化雜志;2016年05期

6 葛瀟;陳文強(qiáng);黃小波;;中醫(yī)辨證論治頸動(dòng)脈粥樣硬化研究概況[J];北京中醫(yī)藥;2016年05期

7 孫寒靜;劉志和;吳艷華;喻騰云;;川芎嗪對(duì)急性腦梗死大鼠CD40/CD40L信號(hào)通路的影響及機(jī)制探討[J];中西醫(yī)結(jié)合心腦血管病雜志;2016年10期

8 劉偉;何佳;;益腎活血解毒湯對(duì)早期動(dòng)脈粥樣硬化家兔CD36表達(dá)及CD40/CD40L途徑的影響[J];中醫(yī)藥臨床雜志;2016年03期

9 朱永坤;黃志恩;潘春予;姚暉;黎鉆弟;陳艷;;補(bǔ)陽(yáng)還五湯對(duì)腦缺血模型大鼠血清中CD40和CD40L含量的影響[J];中國(guó)藥房;2015年25期

10 孫曉偉;李洪濤;欒俊琦;賈寧;劉芷妤;于學(xué)平;滕偉;黃婧;;針刺對(duì)急性頸動(dòng)脈粥樣硬化性腦梗死患者血清sCD40L水平的影響[J];中醫(yī)藥信息;2015年04期

相關(guān)會(huì)議論文 前2條

1 劉中勇;何懷陽(yáng);;動(dòng)脈粥樣硬化(脈痹)中醫(yī)研究進(jìn)展[A];江西省中西醫(yī)結(jié)合學(xué)會(huì)第十次活血化瘀專(zhuān)業(yè)學(xué)術(shù)年會(huì)暨血瘀證與肝腎疾病研究培訓(xùn)班論文集[C];2013年

2 王昌俊;黃旭暉;;頸動(dòng)脈硬化的中醫(yī)診療方案探討[A];第十次中醫(yī)藥防治老年病學(xué)術(shù)交流會(huì)論文集[C];2012年

相關(guān)重要報(bào)紙文章 前1條

1 丁元慶;;從中醫(yī)角度認(rèn)識(shí)CAS斑塊[N];中國(guó)中醫(yī)藥報(bào);2010年

相關(guān)博士學(xué)位論文 前2條

1 張畢奎;CD40/CD40L系統(tǒng)在腦梗塞疾病發(fā)生發(fā)展中的作用及機(jī)制研究[D];中南大學(xué);2013年

2 甄奕;CD40LsiRNA阻斷CD40/CD40L受體配體軸抗動(dòng)脈粥樣硬化的研究[D];第二軍醫(yī)大學(xué);2006年

相關(guān)碩士學(xué)位論文 前8條

1 李成行;針刺調(diào)心方與內(nèi)關(guān)穴對(duì)原發(fā)性高血壓病患者心率變異性影響的對(duì)比觀察[D];山東中醫(yī)藥大學(xué);2014年

2 聶大奧;外周血T細(xì)胞亞群構(gòu)成比例與冠狀動(dòng)脈粥樣硬化關(guān)系的研究[D];南方醫(yī)科大學(xué);2013年

3 蔣群龍;HCY、MMP-9/TIMP-1失衡與頸動(dòng)脈粥樣硬化斑塊穩(wěn)定性的關(guān)系[D];泰山醫(yī)學(xué)院;2013年

4 張?zhí)?MMP-9、TIMP-1、CD147在人粥樣硬化冠狀動(dòng)脈中表達(dá)的相關(guān)性研究[D];大連醫(yī)科大學(xué);2012年

5 任美霞;銀杏提取物對(duì)ACS患者外周血單個(gè)核細(xì)胞CD40/CD40L炎癥信號(hào)傳導(dǎo)的影響[D];浙江大學(xué);2011年

6 劉溪泉;電針“足三里”、“關(guān)元”穴對(duì)亞急性衰老大鼠免疫功能調(diào)節(jié)的實(shí)驗(yàn)研究[D];湖北中醫(yī)學(xué)院;2008年

7 韓志強(qiáng);芪參降脂飲對(duì)SD大鼠外周血及腹主動(dòng)脈CD40/CD40L表達(dá)的影響[D];大連醫(yī)科大學(xué);2006年

8 張悅;溫針灸足三里對(duì)高脂血癥血脂影響的臨床研究[D];山東中醫(yī)藥大學(xué);2005年

，

本文編號(hào)：1794642